Lunai Bioworks (LNAI) Common Equity (2011 - 2026)
Lunai Bioworks' Common Equity came in at -$9.55 million for fiscal Q3 2026 (quarter ended Mar 31, 2026), compared with $88.39 million a year earlier.
Powered by 
Analysis
Lunai Bioworks (LNAI) Common Equity (2011 - 2026) Analysis & Trends
At the end of FY2025 (ended Jun 30, 2025), Lunai Bioworks' Common Equity was -$21.35 million.
- Going back by fiscal year, Common Equity was $131.98 million in FY2024 (+183.8%), $46.5 million in FY2023 (-36.0%), $72.62 million in FY2022 (-58.4%) and $174.66 million in FY2021 (+5.0%).
- The five-year range for quarterly Common Equity is -$21.35 million (fiscal Q4 2025) to $174.66 million (fiscal Q4 2021).
- Year-over-year, Common Equity increased in three of the last four quarters, with growth averaging 86.9%.
- The fastest year-over-year change in Common Equity over five years came in fiscal Q4 2024 (growth of 183.8%), and the weakest in fiscal Q2 2023 (a decline of 59.6%).
- Business Quant data shows LNAI's Common Equity at -$13.55 million (Q2 2026), -$13.04 million (Q1 2026) and -$21.35 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Lunai Bioworks | 5.81 Mn | 1.06 Mn | 20,942.00 | -9.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -9.55 Mn |
| Dec 31, 2025 | -13.55 Mn |
| Sep 30, 2025 | -13.04 Mn |
| Jun 30, 2025 | -21.35 Mn |
| Mar 31, 2025 | 88.39 Mn |
| Dec 31, 2024 | 82.06 Mn |
| Sep 30, 2024 | 98.09 Mn |
| Jun 30, 2024 | 131.98 Mn |
| Mar 31, 2024 | 134.41 Mn |
| Dec 31, 2023 | 43.60 Mn |
| Sep 30, 2023 | 46.75 Mn |
| Jun 30, 2023 | 46.50 Mn |
| Mar 31, 2023 | 66.13 Mn |
| Dec 31, 2022 | 66.90 Mn |
| Sep 30, 2022 | 70.32 Mn |
| Jun 30, 2022 | 72.62 Mn |
| Mar 31, 2022 | 161.24 Mn |
| Dec 31, 2021 | 165.62 Mn |
| Sep 30, 2021 | 166.97 Mn |
| Jun 30, 2021 | 174.66 Mn |
API Access
Lunai Bioworks Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=LNAI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "LNAI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=LNAI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();